...
首页> 外文期刊>Drugs of today: Medicamentos de actualidad >Medicines for Europe-13th Pharmacovigilance Conference (January 29, 2020-Amsterdam, the Netherlands)
【24h】

Medicines for Europe-13th Pharmacovigilance Conference (January 29, 2020-Amsterdam, the Netherlands)

机译:欧洲 - 第13届药剂师会议(2020年1月29日 - 阿姆斯特丹,荷兰)

获取原文
获取原文并翻译 | 示例
           

摘要

This year, following the European Medicines Agency (EMA) relocation due to the Brexit process, the 13th Pharmacovigilance Conference organized by Medicines for Europe took place in Amsterdam, the Netherlands. The pharmaceutical industry is usually associated with the development and launch of new drugs for the market, but it is also committed to finding new ways of making existing drugs and processes (e.g., pharmacovigilance [PV]) more efficient and better for patients. In relation to this, a variety of topics were on the agenda at the conference, including updates on the progress of the EudraVigilance (EV) system for monitoring and analyzing potential drug-related adverse events, as well as highlights on the E.U. Network Strategy to 2025 and the EMA multi-annual work program related to big data acceptability, electronic product information (ePI) Key Principles and Roadmap for implementation, and work-sharing ongoing projects for achieving harmonization of requirements and processes. Adrian van den Hoven (Director General, Medicines for Europe) opened the conference looking towards the future, emphasizing what the current PV system needs to do in order to adapt to new landscapes. With big data, robotization, automation or globalization, there are many opportunities to streamline and become smarter on the horizon.
机译:今年,欧洲药物局(EMA)搬迁由于Brexit进程,由欧洲药物组织的第13届药剂师会议在荷兰阿姆斯特丹进行。制药行业通常与市场开发和发动市场的开发和发动,但也致力于寻找现有药物和过程的新方法(例如,药物检测[PV])对患者更有效,更好。关于这一点,各种主题都在会议上的议程上,包括关于监测和分析潜在的药物相关不良事件的eudraviilance(EV)系统的进展情况,以及E.U的亮点。网络策略到2025年和与大数据可接受性,电子产品信息(EPI)关键原则和路线图有关的EMA多年工作计划,以及用于实现需求和流程协调的工作共享项目。 Adrian Van den Hovern(欧洲药物总干事)开设了对未来的会议,强调当前的光伏系统需要做些什么,以适应新的景观。通过大数据,机器化,自动化或全球化,有很多机会精简并在地平线上变得更聪明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号